REFERENCES
- Chang J H, Gabison E E, Kato T, Azar D T. Corneal neovascularization. Curr Opin Ophthalmol. 2001; 12: 242–249, [PUBMED], [INFOTRIEVE], [CSA]
- Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 2004; 45: 2666–2673, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Holzer M P, Solomon K D, Vroman D T, et al. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization. Invest Ophthalmol Vis Sci 2003; 44: 2954–2958, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Primbs G B, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers 1998; 29: 832–838, [PUBMED], [INFOTRIEVE], [CSA]
- Corrent G, Roussel T J, Tseng S CG, Watson B D. Promation of graft survival by photothrombotic occlusion of corneal neovascularization. Arch Ophthalmol. 1989; 107: 1501–1506, [PUBMED], [INFOTRIEVE], [CSA]
- Mendelsohn A D, Stock E L, Lo G G, Schneck G L. Laser photocoagulation of feeder vessels in lipid keratopathy. Ophthalmic Surg. 1986; 93: 1304–1309, [CSA]
- Pillai C T, Dua H S, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000; 41: 2148–2153, [PUBMED], [INFOTRIEVE], [CSA]
- Gohto Y, Obana A, Kaneda K, Miki T. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998; 67: 313–322, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roberts W, Hasan T. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 1992; 52: 924–930, [PUBMED], [INFOTRIEVE], [CSA]
- Fossarello M, Peiretti E, Zucca I, Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea. 2003; 22: 485–488, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huang A J, Watson B D, Hernandez E, Tseng S CG. Photothrombosis of corneal neovascularization by intravenous rose Bengal and argon laser irradiation. Arch Ophthalmol. 1998; 106: 680–685, [CSA]
- Pallikaris I G, Tslimbaris M K, Iliaki O E, et al. Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675nm). Laser Surg Med 1993; 13: 197–203, [CSA]
- Schmidt-Erfurth U, Hasan T, Schomacker K, et al. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Laser Surg Med 1995; 17: 178–188, [CSA]
- Primbs G B, Casey R, Wamser K, et al. Photodyanmic therapy for corneal neovascularization. Ophthalmol Surg Lasers 1998; 29: 832–838, [CSA]
- Blumenkranz M S, Bressler N M, Bressler S B, et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials—TAP report no. 5. Arch Ophthalmol 2002; 120: 1307–1314, [PUBMED], [INFOTRIEVE], [CSA]
- Blinder K J, Blumenkranz M S, Bressler N M, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP report no. 3. Ophthalmology. 2003; 110: 667–673, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ergun E, Tittl M, Stur M. Photodynamic therapy with verteprofin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol. 2004; 122: 37–41, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kook H, Ahn K Y, Lee S E, et al. Nitric oxide-dependent cytoskeletal changes and inhibition of endothelial cell migration contribute to the suppression of angiogenesis by RAD50 gene transfer. FEBS Lett 2003; 553: 56–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1: 27–31, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Phillips K, Arffa R, Cintron C, et al. Effect of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983; 101: 640–643, [PUBMED], [INFOTRIEVE], [CSA]
- Hayness W L, Proia A D, Klintworth G K. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989; 30: 1588–1593, [CSA]
- Benelli U, Ross J R, Nardi M, Klintworth G K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci. 1997; 38: 274–282, [PUBMED], [INFOTRIEVE], [CSA]
- Joussen A M, Beecken W D, Moromizato Y, et al. Inhibition of inflammatory corneal aniogenensis by TNP–470. Invest Ophthalmol Vis Sci 2001; 42: 2510–2516, [PUBMED], [INFOTRIEVE], [CSA]
- Abbas A, Khan B, Feroze A H, Hyman G F. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis. J Pak Med Assoc. 2002; 52: 476–482, [PUBMED], [INFOTRIEVE], [CSA]
- Duenas Z, Torner L, Corbacho A M, et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci. 1999; 40: 2498–2505, [PUBMED], [INFOTRIEVE], [CSA]
- Joussen A M, Kruse F E, Volcker H E, Kirchhof B. Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 920–927, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kobayashi N, Kabuyama Y, Sasaki S, et al. Supression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 2002; 21: 62–67, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ambati B K, Joussen A M, Ambati J, et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol 2002; 120: 1063–1068, [PUBMED], [INFOTRIEVE], [CSA]
- Wu P C, Liu C C, Chen C H, et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefes Arch Clin Exp Ophthalmol 2003; 241: 63–69, [PUBMED], [INFOTRIEVE], [CSA]
- Lin H C, Chang J H, Jain S, et al. Endostatin localization in the cornea. Invest Ophthalmol Vis Sci. 2000; 41: S832, [CSA]
- Shafiee A, Penn J S, Krutzsch H C, et al. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 2000; 41: 2378–2388, [PUBMED], [INFOTRIEVE], [CSA]
- Cursiefen C, Masli S, Ng T F, et al. Roles of thrombospondin-1 and –2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci 2004; 45: 1117–1124, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005; 115: 2363–2372, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gorrin-Rivas M J, Arii S, Mori A, et al. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. Clin Cancer Res 2000; 6: 1647–1654, [PUBMED], [INFOTRIEVE], [CSA]
- Matsuda K M, Madoiwa S, Hasumi Y, et al. A novel strategy for tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminigen by protease gene transfer. Cancer Gene Ther 2000; 7: 589–596, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stechschulte S, Joussen A, von Recum H, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci 2001; 42: 1975–1979, [PUBMED], [INFOTRIEVE], [CSA]
- Ambati B K, Joussen A M, Kuziel W A, et al. Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 2003; 22: 456–457, [CSA], [CROSSREF]
- Ambati B K, Anand A, Joussen A M, et al. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci 2003; 44: 590–593, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shao C, Sima J, Zhang S X, et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci 2004; 45: 1758–1762, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tsai R J, Li L M, Chen J K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000; 343: 86–93, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sawa M, Awazu K, Takahashi T, et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. Br J Ophthalmol. 2004; 88: 826–831, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Allison B A, Waterfield E, Richter A M, Levy J G. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991; 54: 709–715, [PUBMED], [INFOTRIEVE], [CSA]
- Maziere J C, Santus R, Morliere P, et al. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol 1990; 6: 61–68, [CSA], [CROSSREF]
- Holz E R, Linares L, Mieler W F, Weinberg D V. Exudative complications after photodynamic therapy. Arch Ophthalmol. 2003; 121: 1649–1652, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brooks B J, Ambati B K, Marcus D M, Ratanasit A. Photodynamic therapy for corneal neovasculrization and lipid degeneration. Br J Ophthalmol. 2004; 88: 840, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]